Mitotic chromosomal Bcl-2: II. Localization to interphase nuclei

Journal of Histochemistry and Cytochemistry

Volumn 47, Issue 2, 1999, Pages 151-158

  Schandl, Cynthia A ^a   Li, Shuli ^a   Re, Gian G ^a   Fan, Weimin ^a   Willingham, Mark C ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bax; Bcl 2; Cell cycle; Cell fractionation; Nucleus; Tubulin

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL FRACTIONATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMOSOME; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTERPHASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0032920755     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215549904700204     Document Type: Article

References (23)

1. Alnemri ES, Robertson NM, Fernandes TF, Croce CM, Litwack G (1992) Overexpressed full-length human BCL2 extends the survival of baculovirus-infected SF9 insect cells. Proc Natl Acad Sci USA 89:7295-7299
2. Ashizawa K, Willingham MC, Liang C-M, Cheng S-y (1991) In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate. J Biol Chem 266:16842-16846
3. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB (1997) Identification of a novel regulatory domain in bcl-Xl and bcl-2. EMBO J 16:968-977
4. Collins JA, Schandl CA, Young KK, Vesely J, Willingham MC (1997) Major DNA fragmentation is a late event in apoptosis. J Histochem Cytochem 45:923-934
5. Evans WH (1978) Preparation and Characterization of Mammalian Plasma Membranes. New York, North-Holland Publishing, 47-49
6. Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla, KN (1998) "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res 58:3202-3208
7. Haldar S, Jena N, Croce CM (1994) Antiapoptosis potential of bcl-2 oncogene by dephosphorylation. Biochem Cell Biol 72:455-462
8. Haldar S, Jena N, Croce CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507-4511
9. Huang DC, O'Reilly LA, Strasser A, Cory S (1997) The anti-apoptosis function of bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 16:4628-4638
10. Lu Q-L, Hanby AM, Hajibagheri MAN, Gschmeissner SE, Lu P-J, Taylor-Papadimitriou J, Krajewski S, Reed JC, Wright NA (1994) Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci 107:363-371
11. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong S-L, Ng S-C, Fesik SW (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381:335-341
12. Naumovski L, Cleary ML (1996) The p53-binding protein 53BP2 also interacts with Bcl-2 and impedes cell cycle progression at G2/M. Mol Cell Biol 16:3884-3892
13. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74:609-619
14. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14:18 chromosomal translocation. Am J Pathol 137:225-232
15. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387:773-776
16. Schandl CA, Li S, Re GG, Fan W and Willingham MC (1999) Mitotic chromosomal bcl-2: I. Stable expression throughout the cell cycle and association with isolated chromosomes. J Histochem Cytochem 47:139-149
17. Schandl CA, Priest DG, Willingham MC (1996) Phosphorylation of bcl-2 is a cell cycle-regulated event. Cell Pharm 3:367-372
18. Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214-5218
19. Wang KKW, Posner A, Hajimohammadreza I (1996) Total protein extraction from cultured cells for use in electrophoresis and Western blotting. BioTechniques 20:662-668
20. Wehland J, Willingham MC (1983) A rat monoclonal antibody reacting specifically with the tyrosylated form of alpha-tubulin. J Cell Biol 97:1476-1490
21. Willingham MC, Bhalla K (1994) Transient mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J Histochem Cytochem 42: 441-450
22. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP, Wang X (1997) Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
23. Yin XM, Oltvai ZN, Korsmeyer SJ (1994) BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-333